After Hours Summary: SANM +13%, CDNS +10% higher following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SANM +13%, CDNS +9.6%, RUSHA +3% (light volume), AMP +1.5%
Companies trading higher in after hours in reaction to news: TRMB +4.9% (Trimble to acquire privately-held Viewpoint from Bain Capital in all-cash transaction valued at $1.2 billion - expected to be completed in Q3; expects first quarter revenue to be above the high end of the range of prior guidance), TNDM +3.5% (entered into distribution agreements with Australasian Medical & Scientific and New Zealand Medical & Scientific to commercialize Tandem's t:slim X2 Insulin Pump), ATI +3.3% (ahead of earnings tomorrow), ZYME +2.6% (Zymeworks announced that Celgene exercised its right to expand its collaboration agreement for the research, development, and commercialization of bispecific antibody therapeutics using Zymeworks' Azymetric platform), LQ +2.2% (ticking higher after Sohn announces Idea Contest winner -- Andrew Walker of Rangeley Capital with LQ submission), NWL +1.6% (announced its first quarter 2018 earnings results will be released Friday, May 4; Starboard filed its definitive proxy statement as detailed before the open), PRTA +1.2% (after today's 25 point / 69% decline), PYPL +0.6% (eBay and PayPal finalize new payments agreement), BP +0.5% (upgraded to Buy from Neutral at Goldman)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CVNA -4.7% (also commences 10 mln share follow-on public offering of Class A common stock -- includes 4 mln by selling stockholders), SRCI -3.7% (light volume), AMTD -2.3%, TVTY -1.1%, WHR -0.9%
Companies trading lower in after hours in reaction to news: EPZM -19.6% (announced that U.S.-based enrollment of new patients into tazemetostat clinical trials is temporarily on hold), CASA -4.4% (files for 7.35 mln share common stock offering by holders including Chief Executive Officer and other officers and directors; announces partial lock-up release), AGO -4.1% (dips lower in after hours trade after Greenlight Capital's David Einhorn voices concerns at the Sohn conference), INCY -3.6% (following FDA advisory committee meeting for baricitinib), JOE -3.3% (speculation that JOE will be next Kerrisdale short target), HTZ -1.8% (mentioned cautiously at Sohn conference), EROS -0.9% (light volume; following Mangrove Partners' Nathaniel August cautious comments at Sohn)